Fate Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Operational Progress
Go back to Fate Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Operational Progress| FATE THERAPEUTICS (NASDAQ: FATE) | Delayed: 2.08 -0.09 (4.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.17 | 52 Week High | $4.76 | |||
| Open | $2.13 | 52 Week Low | $1.46 | |||
| Day High | $2.17 | P/E | N/A | |||
| Day Low | $2.01 | EPS | $-1.91 | |||
| Volume | 1,064,419 | |||||
| (NASDAQ: LEGN) | Delayed: 21.63 -0.67 (3%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.30 | 52 Week High | $ | |||
| Open | $22.12 | 52 Week Low | $ | |||
| Day High | $22.42 | P/E | N/A | |||
| Day Low | $21.34 | EPS | $ | |||
| Volume | 2,189,663 | |||||



